AMESITE INC (AMST)

US0310942042 - Common Stock

4.72  -0.08 (-1.67%)

Fundamental Rating

2

Overall AMST gets a fundamental rating of 2 out of 10. We evaluated AMST against 69 industry peers in the Diversified Consumer Services industry. While AMST has a great health rating, there are worries on its profitability. AMST does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

AMST had negative earnings in the past year.
AMST had a negative operating cash flow in the past year.
AMST had negative earnings in each of the past 5 years.
In the past 5 years AMST always reported negative operating cash flow.

1.2 Ratios

AMST has a Return On Assets of -136.60%. This is amonst the worse of the industry: AMST underperforms 96.97% of its industry peers.
AMST's Return On Equity of -184.72% is on the low side compared to the rest of the industry. AMST is outperformed by 81.82% of its industry peers.
Industry RankSector Rank
ROA -136.6%
ROE -184.72%
ROIC N/A
ROA(3y)-100.08%
ROA(5y)-93.25%
ROE(3y)-118.19%
ROE(5y)-118.46%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AMST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

AMST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AMST has about the same amount of shares outstanding.
Compared to 5 years ago, AMST has more shares outstanding
There is no outstanding debt for AMST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -11.39, we must say that AMST is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AMST (-11.39) is worse than 87.88% of its industry peers.
There is no outstanding debt for AMST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.39
ROIC/WACCN/A
WACC9.23%

2.3 Liquidity

AMST has a Current Ratio of 2.96. This indicates that AMST is financially healthy and has no problem in meeting its short term obligations.
AMST's Current ratio of 2.96 is fine compared to the rest of the industry. AMST outperforms 78.79% of its industry peers.
AMST has a Quick Ratio of 2.96. This indicates that AMST is financially healthy and has no problem in meeting its short term obligations.
AMST has a Quick ratio of 2.96. This is amongst the best in the industry. AMST outperforms 80.30% of its industry peers.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 2.96

2

3. Growth

3.1 Past

The earnings per share for AMST have decreased strongly by -25.29% in the last year.
Looking at the last year, AMST shows a very negative growth in Revenue. The Revenue has decreased by -81.58% in the last year.
Measured over the past years, AMST shows a very strong growth in Revenue. The Revenue has been growing by 75.58% on average per year.
EPS 1Y (TTM)-25.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.26%
Revenue 1Y (TTM)-81.58%
Revenue growth 3Y-37.08%
Revenue growth 5Y75.58%
Sales Q2Q%-82.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year150%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMST. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMST. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AMST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMESITE INC

NASDAQ:AMST (12/26/2024, 8:00:01 PM)

4.72

-0.08 (-1.67%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)11-11 2024-11-11/amc
Earnings (Next)02-12 2025-02-12
Inst Owners7.28%
Inst Owner Change-2.75%
Ins Owners23.11%
Ins Owner Change0%
Market Cap13.17M
Analysts82.86
Price TargetN/A
Short Float %1.69%
Short Ratio0.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 114.72
P/FCF N/A
P/OCF N/A
P/B 5.5
P/tB 7.69
EV/EBITDA N/A
EPS(TTM)-1.72
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)-0.95
OCFYN/A
SpS0.04
BVpS0.86
TBVpS0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -136.6%
ROE -184.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-100.08%
ROA(5y)-93.25%
ROE(3y)-118.19%
ROE(5y)-118.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 91.81%
Cap/Sales 399.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.96
Quick Ratio 2.96
Altman-Z -11.39
F-Score2
WACC9.23%
ROIC/WACCN/A
Cap/Depr(3y)69.98%
Cap/Depr(5y)95.16%
Cap/Sales(3y)124.57%
Cap/Sales(5y)366.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.26%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-81.58%
Revenue growth 3Y-37.08%
Revenue growth 5Y75.58%
Sales Q2Q%-82.24%
Revenue Next Year150%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.18%
OCF growth 3YN/A
OCF growth 5YN/A